These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 38810728)

  • 1. Atrial structural remodeling and atrial fibrillation substrate: A histopathological perspective.
    Yamaguchi T
    J Cardiol; 2024 May; ():. PubMed ID: 38810728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histological validation of atrial structural remodelling in patients with atrial fibrillation.
    Takahashi Y; Yamaguchi T; Otsubo T; Nakashima K; Shinzato K; Osako R; Shichida S; Kawano Y; Fukui A; Kawaguchi A; Aishima S; Saito T; Takahashi N; Node K
    Eur Heart J; 2023 Sep; 44(35):3339-3353. PubMed ID: 37350738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human atrial fibrillation substrate: towards a specific fibrotic atrial cardiomyopathy.
    Kottkamp H
    Eur Heart J; 2013 Sep; 34(35):2731-8. PubMed ID: 23761394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electroanatomic remodeling of the left atrium in paroxysmal and persistent atrial fibrillation patients without structural heart disease.
    Teh AW; Kistler PM; Lee G; Medi C; Heck PM; Spence SJ; Sparks PB; Morton JB; Kalman JM
    J Cardiovasc Electrophysiol; 2012 Mar; 23(3):232-8. PubMed ID: 21955090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early Remodeling of the Left Atrium Following Catheter Ablation of Atrial Fibrillation: Insights From DECAAFII.
    Assaf AY; Noujaim C; Mekhael M; Younes H; Chouman N; Dhore-Patil A; Donnellan E; Feng H; Shan B; Kholmovski EG; Marrouche NF; Kreidieh O
    JACC Clin Electrophysiol; 2023 Nov; 9(11):2253-2262. PubMed ID: 37737783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated Circulating Fibrocytes Is a Marker of Left Atrial Fibrosis and Recurrence of Persistent Atrial Fibrillation.
    Liu Y; Niu XH; Yin X; Liu YJ; Han C; Yang J; Huang X; Yu X; Gao L; Yang YZ; Xia YL; Li HH
    J Am Heart Assoc; 2018 Mar; 7(6):. PubMed ID: 29535140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High liver fibrosis scores in metabolic dysfunction-associated fatty liver disease patients are associated with adverse atrial remodeling and atrial fibrillation recurrence following catheter ablation.
    Decoin R; Butruille L; Defrancq T; Robert J; Destrait N; Coisne A; Aghezzaf S; Woitrain E; Gouda Z; Schino S; Klein C; Maboudou P; Brigadeau F; Klug D; Vincentelli A; Dombrowicz D; Staels B; Montaigne D; Ninni S
    Front Endocrinol (Lausanne); 2022; 13():957245. PubMed ID: 36120456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of DrOnedarone on atrial fibrosis progression and atrial fibrillation recurrence postablation: Design of the EDORA randomized clinical trial.
    Marrouche NF; Dagher L; Wazni O; Akoum N; Mansour M; El Hajjar AH; Bhatnagar A; Hua H;
    J Cardiovasc Electrophysiol; 2021 Dec; 32(12):3203-3210. PubMed ID: 34664772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atrial substrate characterization in patients with atrial fibrillation and hypertrophic cardiomyopathy: Evidence for an extensive fibrotic disease.
    Efremidis M; Bazoukis G; Vlachos K; Prappa E; Anastasakis A; Megarisiotou A; Dragasis S; Asvestas D; Mililis P; Saplaouras A; Efremidis T; Batsouli A; Zimpounoumi N; Valkanas K; Sideris A; Letsas KP
    J Electrocardiol; 2021; 69():87-92. PubMed ID: 34619440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multimodality Imaging for Atrial Fibrosis Detection in the Era of Precision Medicine.
    Barletta V; Mazzocchetti L; Parollo M; Spatafora D; Bongiorni MG; Zucchelli G
    J Cardiovasc Echogr; 2021; 31(4):189-197. PubMed ID: 35284213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of Left Atrial Voltage Distribution Between Sinus Rhythm and Atrial Fibrillation: Identifying Structural Remodeling by 3-D Electroanatomic Mapping Irrespective of the Rhythm.
    Yagishita A; DE Oliveira S; Cakulev I; Gimbel JR; Sparano D; Manyam H; Manrique-Garcia A; Arredondo M; Mackall J; Arruda M
    J Cardiovasc Electrophysiol; 2016 Aug; 27(8):905-12. PubMed ID: 27135965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progressive and Simultaneous Right and Left Atrial Remodeling Uncovered by a Comprehensive Magnetic Resonance Assessment in Atrial Fibrillation.
    Gunturiz-Beltrán C; Nuñez-Garcia M; Althoff TF; Borràs R; Figueras I Ventura RM; Garre P; Caixal G; Prat-González S; Perea RJ; Benito EM; Tolosana JM; Arbelo E; Roca-Luque I; Brugada J; Sitges M; Mont L; Guasch E
    J Am Heart Assoc; 2022 Oct; 11(20):e026028. PubMed ID: 36216438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-Term Outcome of Left Atrial Voltage-Guided Substrate Ablation During Atrial Fibrillation: A Novel Adjunctive Ablation Strategy.
    Yagishita A; Gimbel JR; DE Oliveira S; Manyam H; Sparano D; Cakulev I; Mackall J; Arruda M
    J Cardiovasc Electrophysiol; 2017 Feb; 28(2):147-155. PubMed ID: 27862561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of Left Atrial Fibrosis and Success of Catheter Ablation by Speckle Tracking Echocardiography in Patients Imaged in Persistent Atrial Fibrillation.
    Marchandise S; Garnir Q; Scavée C; Varnavas V; le Polain de Waroux JB; Wauters A; Beauloye C; Roelants V; Gerber BL
    Front Cardiovasc Med; 2022; 9():856796. PubMed ID: 35694674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of left atrial remodeling by 2D-speckle-tracking echocardiography versus by high-density voltage mapping in patients with atrial fibrillation.
    Laish-Farkash A; Perelshtein Brezinov O; Valdman A; Tam D; Rahkovich M; Kogan Y; Marincheva G
    J Cardiovasc Electrophysiol; 2021 Feb; 32(2):305-315. PubMed ID: 33331056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic Effects of Weight Loss and Catheter Ablation: Can microRNAs Serve as Predictive Biomarkers for the Prevention of Atrial Fibrillation Recurrence?
    Förster CY; Künzel SR; Shityakov S; Stavrakis S
    Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38731908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Role of Atrial Structural Remodeling in Atrial Fibrillation Ablation:An Imaging Point of View for Predicting Recurrence.
    Akutsu Y; Tanno K; Kobayashi Y
    J Atr Fibrillation; 2012; 5(2):509. PubMed ID: 28496757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term effects of catheter ablation for lone atrial fibrillation: progressive atrial electroanatomic substrate remodeling despite successful ablation.
    Teh AW; Kistler PM; Lee G; Medi C; Heck PM; Spence SJ; Morton JB; Sanders P; Kalman JM
    Heart Rhythm; 2012 Apr; 9(4):473-80. PubMed ID: 22079885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Total atrial conduction time as a possible predictor of atrial fibrillation recurrence after catheter ablation for paroxysmal atrial fibrillation: relationship between electrical atrial remodeling and structural atrial remodeling time courses.
    Maenosono R; Mizukami N; Ichiki H; Oketani N; Namino F; Masamoto I; Yuasa T; Yamakuchi M; Ohishi M; Hashiguchi T
    J Med Ultrason (2001); 2021 Jul; 48(3):295-306. PubMed ID: 33913054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and electrophysiological characterization of early left atrial structural remodeling as a predictor for atrial fibrillation recurrence after pulmonary vein isolation.
    Yagishita A; Sparano D; Cakulev I; Gimbel JR; Phelan T; Mustafa H; De Oliveira S; Mackall J; Arruda M
    J Cardiovasc Electrophysiol; 2017 Jun; 28(6):642-650. PubMed ID: 28387462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.